Elvitegravir

Paul A. Pham, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D.
Elvitegravir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of HIV-infection as part of a single tablet regimen (e.g., Stribild, Genvoya) for adults who are ART-naive or to replace a stable regimen in patients who are virologically suppressed

NON-FDA APPROVED USES

Treatment of HIV-infection for adults who are ARV-experienced but not virologically suppressed on a stable regimen

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of HIV-infection as part of a single tablet regimen (e.g., Stribild, Genvoya) for adults who are ART-naive or to replace a stable regimen in patients who are virologically suppressed

NON-FDA APPROVED USES

Treatment of HIV-infection for adults who are ARV-experienced but not virologically suppressed on a stable regimen

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: November 3, 2016